The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by GSK .

Filed returns
34
match these filters
Matching filed returns per period 0 1 2 3 5 Sep–Dec 2015: 1 filed returns Jan–Apr 2019: 1 filed returns May–Aug 2023: 2 filed returns Sep–Dec 2023: 1 filed returns Jan–Apr 2024: 4 filed returns May–Aug 2024: 4 filed returns Sep–Dec 2024: 5 filed returns Jan–Apr 2025: 4 filed returns May–Aug 2025: 3 filed returns Sep–Dec 2025: 3 filed returns Jan–Apr 2026: 2 filed returns May–Aug 2026: 3 filed returns Sep–Dec 2026: 1 filed returns (partial: returns still being filed) 2019 2024 2025 2026
Filed returns per four-month period Newest period: partial, returns still being filed Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2026 GSK Health HIV Policy (Public policy or programme) 2 On lobbying.ie
May–Aug 2026 GSK Health Biotech Act, Respiratory and Oncology policy at EU level (Legislation) 1 On lobbying.ie
May–Aug 2026 GSK Health Vaccines policy (Public policy or programme) 21 On lobbying.ie
May–Aug 2026 GSK Health Vaccines policy (Public policy or programme) 10 On lobbying.ie
Jan–Apr 2026 GSK Health Adult immunisation policy (Public policy or programme) 10 On lobbying.ie
Jan–Apr 2026 GSK Health HIV treatment and prevention (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2025 GSK Health Information regarding HIV in Ireland (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2025 GSK Health Shingles Immunisation policy (Public policy or programme) 10 On lobbying.ie
Sep–Dec 2025 GSK Health Immunisation against RSV (Public policy or programme) 11 On lobbying.ie
May–Aug 2025 GSK Health Vaccination policy (Public policy or programme) 20 On lobbying.ie
May–Aug 2025 GSK Health Investment in treatment of HIV (Public policy or programme) 9 On lobbying.ie
May–Aug 2025 GSK Health Access and reimbursement timelines for medicines (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2025 GSK Health Sustainability in Life Sciences (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2025 GSK Health Immunisation policy (Public policy or programme) 23 On lobbying.ie
Jan–Apr 2025 GSK Health Immunisation policy (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2025 GSK Health Immunisation policy (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2024 GSK Health Adult, RSV and Shingles Vaccination policy (Public policy or programme) 6 On lobbying.ie
Sep–Dec 2024 GSK Health Shingles vaccination policy (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2024 GSK Health Older adults RSV pathfinder programme (Public policy or programme) 8 On lobbying.ie
Sep–Dec 2024 GSK Health Vaccination policy (Public policy or programme) 9 On lobbying.ie
Sep–Dec 2024 GSK Health To demonstrate return on investment from adult vaccination (Public policy or programme) 22 On lobbying.ie
May–Aug 2024 GSK Health Update on reimbursement process for Jemperli (Matters involving public funds) 2 On lobbying.ie
May–Aug 2024 GSK Health RSV vaccination for older adults (Public policy or programme) 6 On lobbying.ie
May–Aug 2024 GSK Health Shingles vaccination for older adults (Public policy or programme) 8 On lobbying.ie
May–Aug 2024 GSK Health Adult vaccination (Public policy or programme) 193 On lobbying.ie
Jan–Apr 2024 GSK Health Shingles vaccination (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2024 GSK Health EU legislation (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2024 GSK Health Immunisation policy (Public policy or programme) 10 On lobbying.ie
Jan–Apr 2024 GSK Health Immunisation policy (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2023 GSK Health Immunisation policy (Public policy or programme) 15 On lobbying.ie
May–Aug 2023 GSK Health Diverting funds not spent on COVID (Matters involving public funds) 2 On lobbying.ie
May–Aug 2023 GSK Health Immunisation policy (Public policy or programme) 6 On lobbying.ie
Jan–Apr 2019 GSK Health No specific piece of legislation. Rather a meeting around Slainte Care and chronic disease management (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2015 GSK Health On October 2nd, 2015, GSK met with the Special Adviser assigned to the Minister for Health to discuss GSK's recent aquisition of Novartis' vaccines portfolio and the potential to broaden the National Immunisation… (Public policy or programme) 1 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 34 100.0%